```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. 3193 Introduced in Senate (IS)]

<DOC>

118th CONGRESS
  1st Session
                                S. 3193

    To amend the Controlled Substances Act to allow for the use of 
telehealth in substance use disorder treatment, and for other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            November 1, 2023

Mr. Whitehouse (for himself, Ms. Murkowski, Mr. Warner, Mrs. Blackburn, 
 Ms. Cortez Masto, Mr. Tillis, Mr. Kaine, Mrs. Capito, Ms. Klobuchar, 
  Mr. Kelly, and Mr. Booker) introduced the following bill; which was 
 read twice and referred to the Committee on Health, Education, Labor, 
                              and Pensions

_______________________________________________________________________

                                 A BILL

 
    To amend the Controlled Substances Act to allow for the use of 
telehealth in substance use disorder treatment, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Telehealth Response for E-
prescribing Addiction Therapy Services Act'' or the ``TREATS Act''.

SEC. 2. TELEHEALTH FOR SUBSTANCE USE DISORDER TREATMENT.

    Section 309(e)(2) of the Controlled Substances Act (21 U.S.C. 
829(e)(2)) is amended--
            (1) in subparagraph (A)(i)--
                    (A) by striking ``at least 1 in-person medical 
                evaluation'' and inserting the following: ``at least--
                                    ``(I) 1 in-person medical 
                                evaluation''; and
                    (B) by adding at the end the following:
                                    ``(II) for purposes of prescribing 
                                a controlled substance in schedule III, 
                                IV, or V that has been approved by the 
                                Food and Drug Administration for the 
                                treatment of a substance use disorder, 
                                1 telehealth evaluation of the patient; 
                                or''; and
            (2) by adding at the end the following:
                    ``(D) The term `telehealth evaluation' means a 
                medical evaluation that is conducted in accordance with 
                applicable Federal and State laws by a practitioner 
                (other than a pharmacist) who is at a location remote 
                from the patient and is communicating with the patient, 
                or a practitioner who is treating the patient, using a 
                telecommunications system referred to in section 
                1834(m) of the Social Security Act (42 U.S.C. 1395m(m)) 
                that includes audio-only or audio and video equipment 
                permitting two-way, real-time interactive communication 
                between the distant site practitioner and the patient, 
                or the practitioner who is treating the patient.''.
                                 <all>
```